SCHEMBL12904313

SCHEMBL12904313

Cc1cc(CBr)c2oc(-c3ccncc3)cc(=O)c2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 1/20 0.56
▸ PIK3CA P42336 1/20 0.56
▸ PIK3CB P42338 1/20 0.56
▸ PIK3CG P48736 1/20 0.56
▸ CSNK2A2 P19784 8/20 0.52
▸ CSNK2B P67870 8/20 0.52
▸ CSNK2A1 P68400 8/20 0.52
▸ CYP1A2 P05177 4/20 0.50
▸ CYP1A1 P04798 3/20 0.50
▸ CYP1B1 Q16678 3/20 0.50
▸ CFTR P13569 2/20 0.49
▸ CYP3A4 P08684 2/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ NCOA1 Q15788 1/20 0.48
▸ NCOA3 Q9Y6Q9 1/20 0.48
▸ POLB P06746 1/20 0.48
▸ QPCT Q16769 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6132108 0.85 PIK3CD (0.52) PIK3CDPIK3CAPIK3CBPIK3CGCSNK2A2
SCHEMBL910015 0.83 PIK3CD (0.57) PIK3CDPIK3CAPIK3CBPIK3CGCSNK2A2
SCHEMBL909859 0.81 PIK3CD (0.67) PIK3CDPIK3CAPIK3CBPIK3CGCSNK2A2
SCHEMBL6132106 0.79 PIK3CD (0.47) PIK3CDPIK3CAPIK3CBPIK3CGCSNK2A2
Alcohol SCHEMBL6004304 0.79 PIK3CA (0.61) PIK3CDPIK3CAPIK3CBPIK3CGCSNK2A2
SCHEMBL1461301 0.79 PIK3CD (0.61) PIK3CDPIK3CAPIK3CBPIK3CGCSNK2A2
SCHEMBL910336 0.79 PIK3CD (0.67) PIK3CDPIK3CAPIK3CBPIK3CGCSNK2A2
SCHEMBL909776 0.77 PIK3CD (0.54) PIK3CDPIK3CAPIK3CBPIK3CGCSNK2A2
SCHEMBL6132112 0.76 PIK3CD (0.50) PIK3CDPIK3CAPIK3CBPIK3CGCSNK2A2
SCHEMBL6132103 0.75 PIK3CA (0.45) PIK3CDPIK3CAPIK3CBPIK3CGCSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7872011-B2 Inhibition of phosphoinositide 3-kinase β ASTRAZENECA AB (SE) 2011-01-18 — — US disclosed
US-7872011-B2 Inhibition of phosphoinositide 3-kinase β ASTRAZENECA AB (SE) 2011-01-18 — — US disclosed
US-7598377-B2 (+-)-7-Methyl-2-morpholin-4-yl-9-(1-phenylaminoethyl)-pyrido[1,2-a]pyrimidin-4-one, for example; selective inhibitors of phosphoinositide (PI) 3-kinase beta for use in anti-thrombotic therapy ASTRAZENECA AB (SE) 2009-10-06 — — US disclosed
US-7598377-B2 (+-)-7-Methyl-2-morpholin-4-yl-9-(1-phenylaminoethyl)-pyrido[1,2-a]pyrimidin-4-one, for example; selective inhibitors of phosphoinositide (PI) 3-kinase beta for use in anti-thrombotic therapy ASTRAZENECA AB (SE) 2009-10-06 — — US disclosed
US-20080319021-A1 Inhibition Of Phosphoinositide 3-Kinase Beta KINACIA PTY. LTD. (AU) 2008-12-25 — — US disclosed
US-20080319021-A1 Inhibition Of Phosphoinositide 3-Kinase Beta KINACIA PTY. LTD. (AU) 2008-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080319021-A1 Inhibition Of Phosphoinositide 3-Kinase Beta PI4KB, PI4KA, PI4K2B PIK3CD 8/4885PIK3CA 11/4885PIK3CB 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback